Is it Getting Breezy In Here? Biotech IPO Climate Improving

Don't look now, biotech IPO prices are getting better. But VCs still prefer M&A. Here's a look at biotech IPOs from the past two years: average cash raised, total cash raised and total successful IPOs.

More from Strategy

More from Business